Merck’s Keytruda Expected to Hit $17 Billion Yearly Revenue
Merck’s Keytruda continues to generate billion-dollar sales. The oncology drug reached $4.5 billion of sales in the third quarter, making [...]
Syapse Announces RWD Partnership with Merck to Accelerate Oncology Research and Improve Patient Outcomes
Real world evidence (RWE) leader Syapse has announced a partnership with Merck. Together, the companies will utilize real world data [...]
Merck and Amgen Boldly Test the Limits of Prescription Drug Price Increases
Pharmaceutical companies generally keep drug prices increases around 5% per year. This year, Merck and Amgen tested that unofficial limit. [...]
Trump Administration Picks Five Companies in Operation Warp Speed
The Trump administration has selected five drugmakers as being most likely to develop a coronavirus vaccine, The New York Times [...]
Balancing Innovation, Common Sense to Deliver Innovative Medicines
Merck & Co.'s Mark Travers during the 9th Annual DPharm: Disruptive Innovations conference discussed how to best balance innovation with [...]
Advertisement
